Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  acetylsalicylic acid
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 29 for your search:
Start Over
Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?
Phase: Phase IV
Type: Supportive care
Status: Enrolling by invitation
Age: 18 to 80
Sponsor: Other
Protocol IDs: PZ-1001-403-NS, NCT01621451
ASPREE Cancer Endpoints Study
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Enrolling by invitation
Age: 65 and over
Sponsor: NCI, Other
Protocol IDs: 3U01AG029824-02S1, NCT01968798
Peri-operative Aspirin Continuation Versus Discontinuation
Phase: Phase IV
Type: Health services research, Supportive care
Status: Enrolling by invitation
Age: 18 and over
Sponsor: Other
Protocol IDs: RMC-13-0666, NCT02350543
Phase III Study of L-PAM vs P-32 and Persantine plus Aspirin vs Placebo for Thrombocytic Myeloproliferative Disorders
Phase: Phase III
Type: Treatment
Status: Closed
Age: 30 and over
Sponsor:
Protocol IDs: PVSG-10
Phase III Randomized Comparison of Recombinant IFN-A with vs without Aspirin in Patients with Advanced Renal Adenocarcinoma (Summary Last Modified 01/90)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-875001, MAYO-875001, NCCTG-87-50-01
Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
Phase: Phase III
Type: Prevention
Status: Completed
Age: over 30 to under 75
Sponsor: NCI, Other
Protocol IDs: CDR0000078380, CLB-9270, E-C9270, NCCTG-949251, NCI-P93-0048, NCT00002527
A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia
Phase: Phase III
Type: Biomarker/Laboratory analysis, Health services research, Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000491649, OCTO-003, 2004-003836-77, ISRCTN85156844, OCTO-ASPECT, RADCLIFFE-32, ZENECA-RADCLIFFE-32, EUDRACT-2004-003836-77, EU-20628, NCT00357682
Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03150, CDR0000404161, E4A03, U10CA021115, U10CA180820, ECOG-E4A03, NCT00098475
Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
Phase: Phase III
Type: Prevention
Status: Completed
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: 69, R01HL043851, HL043851, CA047988, NCT00000479
Phase I/II Study of Chemoimmunotherapy with CTX/DOX/IFN-alfa plus IL-2/LAK Cells in Patients with Malignant Melanoma or Renal Cell Carcinoma (Summary Last Modified 12/92)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8802D, NCI-88-C-84D, NCI-T88-0103N, T88-0103
Phase I/II Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: HEMMYL0018, AR_MM_PI_007, SU-05062011-7711, 19092, NCT01355705
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000068028, NCI-00-C-0128, MB-401, NCI-T99-0066, T99-0066, NCT00020189
Phase II Immunotherapy with IFL-rA plus Aspirin in Patients with Disseminated Malignant Melanoma and Advanced Renal Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MAYO-851901, NCI-T85-0264D, T85-0264
Phase II Study of the Role of Nonsteroidal Anti-Inflammatory Agents in the Control of Pancreatic Cancer Pain (Summary Last Modified 09/89)
Phase: Phase II
Type: Supportive care
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: RPMI-DS-8816, NCI-V88-0553
A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-0427 / 201107340, NCT00263211
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00838, MAY04-4-01, CDR0000544180, MAYO-MAY04-4-01, N01CN35000, NCT00474903
A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: RV-PI-0103, 07/04, NCT00482261
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: Under 75
Sponsor: NCI
Protocol IDs: NCI-2009-00841, CDR0000652929, NCI 04-2-03, NWU04-2-03, N01CN35157, NU-NWU04-2-03, NCT00468910
Phase I Chemoprevention Study of Aspirin in Patients at High Risk for Colorectal Cancer (Summary Last Modified 06/94)
Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CCUM-9215, NCI-P93-0040
Phase I Study of Acetylsalicylic Acid Mouthwash in Patients With Oral Leukoplakia. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information.
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Not specified
Sponsor: Other
Protocol IDs: INHANSE-ASPOD, ASPOD, EU-21083, ASPOD, ISRCTN-31503555, EU-21083, NCT01238185
FUDR/MITO Hepatic Artery Infusion with or without C. Parvum Immunotherapy for Liver Metastases of Colorectal Cancer
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7803
Phlebotomy plus P-32 vs Phlebotomy plus Antiaggregating Therapy for Polycythemia Vera
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor:
Protocol IDs: PVSG-5
Start Over